Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1283, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
STI 571 strengthens its standing in CML
Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. :
Access to resources
Recommend
STI 571 teams up to trick CML cells into self-betrayal
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
STI 571 active in patients with rare GI cancer
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :
Natalizumab in MS well tolerated
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :